SARS-CoV-2 Spike Glycoprotein-Omicron-90% purity
SARS-CoV-2 Spike Glycoprotein-Omicron-90% purity
| RP30219 | |
|
|
|
| ￥6860 | |
|
|
|
|
|
|
| 联系我们 | |
| RP30219 | |
|
|
|
| ￥6860 | |
|
|
|
|
|
|
| 联系我们 | |
| Description |
This pool is
delivered in two sub-pools of 158 & 157 peptides derived from a peptide
scan (15mers with 11 aa overlap) through the entire Spike glycoprotein of
SARS-CoV-2 B.1.1.529 (Severe Acute Respiratory Syndrome-related coronavirus 2,
Lineage B.1.1.529, South Africa, Omicron) covering the following mutations:
A67V, H69-, V70-, T95I, G142-, V143-, Y144-, Y145D, N211-, L212I, "EPE"
insertion between 214R and 215D, G339D, S371L, S373P, S375F, K417N, N440K,
G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G,
H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. |
| Sequence |
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS NVTWFHVISGTNGTKRFDNPVLPFNDGVYFASIEKSNIIRGWIFGTTLDSKTQSLLIVNN ATNVVIKVCEFQFCNDPFLDHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGN FKNLREFVFKNIDGYFKIYSKHTPIIVREPEDLPQGFSALEPLVDLPIGINITRFQTLLA LHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTL KSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFDEVFNATRFASVYAWNRKRISNCVA DYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGNIADYNY KLPDDFTGCVIAWNSNKLDSKVSGNYNYLYRLFRKSNLKPFERDISTEIYQAGNKPCNGV AGFNCYFPLRSYSFRPTYGVGHQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNF NGLKGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTN TSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEYVNNSYECD IPIGAGICASYQTQTKSHRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVT TEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLKRALTGIAVEQDKNTQEVFA QVKQIYKTPPIKYFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGD IAARDLICAQKFKGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMA YRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNHNAQALNTLV KQLSSKFGAISSVLNDIFSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASAN LAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICH DGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQP ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL GKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEP VLKGVKLHYT |
| Source |
Severe
Acute Respiratory Syndrome-related coronavirus 2 (Spike B.1.1.529) Spike
glycoprotein (covering the following mutations: A67V, H69-, V70-, T95I, G142-, V143-, Y144-, Y145D, N211-, L212I,
"EPE" insertion between 214R and 215D, G339D, S371L, S373P, S375F,
K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H,
T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F). |
| Gene ID |
S |
| Length |
1270 aa |
| Purity |
90% by RP-HPLC (Major
peak by ESI-MS is guaranteed to be peptide of interest - determined at 220 nm
for each individual peptide). |
| Solubility | Dissolve in a minimum amount of pure DMSO (approx. 50 µl) and dilute with PBS buffer to the final concentration. Please note that the final concentration of DMSO must be below 1 % (v/v) to avoid toxicity in the biological system. |
| Form |
Lyophilized |
| Storage |
Store at -20°C. |
| Note |
The
peptides of this product are supplied as trifluoroacetate salts. |
